Gene Therapy Death, FDA Blunders, and a Chilling Effect on Transparency
The weekend's revelations – a young girl's death in a gene therapy trial, the FDA's retraction of a lettuce test result, and the ADA's delayed editorial – chip away at fundamental expectations of transparency and accountability.
1 day ago